Attachment J-4 Sample Client Letter.pdf

PDF 29 KB Posted

Attached to
FDA Jefferson Labs, Bldg. 5(D) roof replacement to include demolition and renovation of interior space
Solicitation number
75F40120R00010
Issued by

About this file

Written by GovTribe AI ·

This document contains a sample client letter and information about a federal contract opportunity for roof replacement services. The letter is from an offering entity to a client, requesting that the client complete a past performance evaluation questionnaire to be submitted to the Food and Drug Administration (FDA) by April 9, 2020 regarding Solicitation Number 75F40120R00010. The solicitation is for Building 5D roof replacement and interior renovation work at the FDA's National Center for Toxicological Research facility in Jefferson, Arkansas. The questionnaire is a key input to the source selection process and clients should send it directly to the specified FDA contracting staff no later than the stated deadline. The contract opportunity is being conducted by the FDA to replace the roof of Building 5D and renovate interior spaces at their Jefferson Laboratories Complex location.

View the file

Other files

File Type Posted
75F40120R00010 Amendment 3.pdf PDF
75F40120R00010 Amendment 0002.pdf PDF
75F40120R00010 Amendment 0001 .pdf PDF
Attachment J-2 Drawings.pdf PDF
ATTACHMENT J-3 U.S. Dept. of Labor General Decision No. AR20200036.pdf PDF
Attachment J-5 PP Eval Questionnaire.pdf PDF
Attachment J-1 Project Manual.pdf PDF
FDA Solicitation 75F40120R00010.pdf PDF
Attachment J-6 FDA Form 3398.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Attachment J-4: Sample Client Letter

SAMPLE CLIENT LETTER

Dear Client, We are currently responding to Solicitation Number 75F40120R00010 for Building 5D Roof Replacement, at the U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR), 3900 NCTR Road, Jefferson, Arkansas 72079. The FDA has emphasized past performance as a key source selection factor, and requires that clients of entities responding to their solicitations be identified and their participation in the evaluation process be requested.

To that end, enclosed for your completion is a Present and Past Performance Evaluation Questionnaire. We request that you complete the questionnaire and send it directly to the FDA at the following address no later than 2:00 PM Central Time on April 9, 2020:

U. S. Food and Drug Administration Jefferson Laboratories Complex National Center for Toxicological Research Division of Acquisition Programs Field Operation Branch, HFT-320 Attn: Tim Walbert, Contract Specialist 3900 NCTR Road, Bldg 50, Rm 426 Jefferson, AR 72079

The questionnaire can also be faxed to 870-543-7990 or emailed to timothy.walbert@fda.hhs.gov. Again, the questionnaire shall be submitted by no later than 2:00 PM Central Time on April 9, 2020.

For questions or additional assistance regarding the attached questionnaire, please contact Tim Walbert, FDA Contract Specialist at 870-543-7267 or timothy.walbert@fda.hhs.gov.

Thanks very much for your consideration and prompt response regarding this matter.

Sincerely, {Offering Entity}

File details come from the government source that posted it. Updated .